← All organizations
Highest phase reached
Phase 3
First clinical trial
Aug 1, 2008Last known activity
Jul 11, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 4 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Indications
Recent trials (8)
- NCT05955040Lead sponsorPhase 2Jul 11, 2023
- NCT05955040Reponsible party - principal investigatorPhase 2Jul 11, 2023
- NCT03147638Lead sponsorPhase 3Jan 11, 2017
- NCT03147638Reponsible party - principal investigatorPhase 3Jan 11, 2017
- NCT01102426Overall official - principal investigatorPhase 3Jun 1, 2010
- NCT00899353Reponsible party - principal investigatorPhase 2Aug 1, 2008
- NCT00899353Lead sponsorPhase 2Aug 1, 2008
- NCT00899353Overall official - principal investigatorPhase 2Aug 1, 2008
Details
- Last known activity
- Jul 11, 2023